Cargando…
An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma
BACKGROUND: An immune-related gene signature (IGS) was established for discriminating prognosis, predicting benefit of immunotherapy, and exploring therapeutic options in hepatocellular carcinoma (HCC). METHODS: Based on Immune-related hub genes and The Cancer Genome Atlas (TCGA) LIHC dataset (n = 3...
Autores principales: | Yao, Ninghua, Jiang, Wei, Wang, Yilang, Song, Qianqian, Cao, Xiaolei, Zheng, Wenjie, Zhang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015788/ https://www.ncbi.nlm.nih.gov/pubmed/36918943 http://dx.doi.org/10.1186/s40001-023-01091-w |
Ejemplares similares
-
A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma
por: Dai, Xiaoyan, et al.
Publicado: (2021) -
Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma
por: Wang, Xiaodong, et al.
Publicado: (2022) -
A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
por: Wu, Jingyi, et al.
Publicado: (2023) -
An Integrating Immune-Related Signature to Improve Prognosis of Hepatocellular Carcinoma
por: Zhu, Rui, et al.
Publicado: (2020) -
An inflammation‐associated ferroptosis signature optimizes the diagnosis, prognosis evaluation and immunotherapy options in hepatocellular carcinoma
por: Ruan, Wan‐Yuan, et al.
Publicado: (2023)